146 related articles for article (PubMed ID: 29503569)
1. Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells.
Wang X; Liu Y; Wu R; Guo F; Zhang L; Cui M; Wu X; Zhang Y; Liu W
Onco Targets Ther; 2018; 11():943-953. PubMed ID: 29503569
[TBL] [Abstract][Full Text] [Related]
2. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
[TBL] [Abstract][Full Text] [Related]
3. Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner.
Wang X; Liu Y; Liu W; Zhang Y; Guo F; Zhang L; Cui M; Liu S; Wu R
Mol Med Rep; 2018 Mar; 17(3):4531-4539. PubMed ID: 29328441
[TBL] [Abstract][Full Text] [Related]
4. Ubenimex enhances the radiosensitivity of renal cell carcinoma cells by inducing autophagic cell death.
Liu S; Wang X; Lu J; Han L; Zhang Y; Liu Z; Ding S; Liu Z; Bi D; Niu Z
Oncol Lett; 2016 Nov; 12(5):3403-3410. PubMed ID: 27900012
[TBL] [Abstract][Full Text] [Related]
5. Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway.
Wang Y; Pang B; Zhang R; Fu Y; Pang Q
Drug Des Devel Ther; 2019; 13():3217-3228. PubMed ID: 31571825
[TBL] [Abstract][Full Text] [Related]
6. Autophagy flux inhibition, G2/M cell cycle arrest and apoptosis induction by ubenimex in glioma cell lines.
Han L; Zhang Y; Liu S; Zhao Q; Liang X; Ma Z; Gupta PK; Zhao M; Wang A
Oncotarget; 2017 Dec; 8(64):107730-107743. PubMed ID: 29296201
[TBL] [Abstract][Full Text] [Related]
7. Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated.
Liu S; Xie F; Wang H; Liu Z; Liu X; Sun L; Niu Z
Oncol Rep; 2015 Mar; 33(3):1372-80. PubMed ID: 25571917
[TBL] [Abstract][Full Text] [Related]
8. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
9. Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells.
Han L; Zhao Q; Liang X; Wang X; Zhang Z; Ma Z; Zhao M; Wang A; Liu S
Oncotarget; 2017 Jul; 8(28):45643-45655. PubMed ID: 28484091
[TBL] [Abstract][Full Text] [Related]
10. Ubenimex suppresses glycolysis mediated by CD13/Hedgehog signaling to enhance the effect of cisplatin in liver cancer.
Shi Y; Guo Q; Jing F; Shang X; Zhou C; Jing F
Transl Cancer Res; 2023 Oct; 12(10):2823-2836. PubMed ID: 37969369
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of tumor cell invasion and induction of apoptosis by ubenimex].
Zheng YB; Gong JH; Li Y; Zhen YS
Yao Xue Xue Bao; 2012 Dec; 47(12):1593-8. PubMed ID: 23460963
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
Li X; Li Z; Li X; Liu B; Liu Z
BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
[TBL] [Abstract][Full Text] [Related]
13. CD13 downregulation mediated by ubenimex inhibits autophagy to overcome 5-FU resistance by disturbing the EMP3/FAK/NF-κB pathway in gastric cancer cells.
Xiu T; Guo Q; Jing F; Shi Y; Jing F
Transl Cancer Res; 2022 Aug; 11(8):2487-2500. PubMed ID: 36093528
[TBL] [Abstract][Full Text] [Related]
14. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
[TBL] [Abstract][Full Text] [Related]
15. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
Yao X; Jiang W; Yu D; Yan Z
Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of kaempferol in A375 human malignant melanoma cells are mediated via induction of apoptosis, cell cycle arrest, inhibition of cell migration and downregulation of m-TOR/PI3K/AKT pathway.
Yang J; Xiao P; Sun J; Guo L
J BUON; 2018; 23(1):218-223. PubMed ID: 29552787
[TBL] [Abstract][Full Text] [Related]
17. Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K/Akt and MAPK/ERK pathways.
Peng X; Wang Z; Liu Y; Peng X; Liu Y; Zhu S; Zhang Z; Qiu Y; Jin M; Wang R; Zhang Q; Kong D
Life Sci; 2018 Aug; 206():35-44. PubMed ID: 29782872
[TBL] [Abstract][Full Text] [Related]
18. Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway.
Li W; Li G; She W; Hu X; Wu X
J BUON; 2019; 24(5):2056-2061. PubMed ID: 31786875
[TBL] [Abstract][Full Text] [Related]
19. Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
Liu S; Gao M; Wang X; Ding S; Lv J; Gao D; Wang Z; Niu Z
Oncotarget; 2016 Nov; 7(48):79141-79153. PubMed ID: 27816967
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside G-Rh2 synergizes with SMI-4a in anti-melanoma activity through autophagic cell death.
Lv DL; Chen L; Ding W; Zhang W; Wang HL; Wang S; Liu WB
Chin Med; 2018; 13():11. PubMed ID: 29483938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
